OncoTargets and Therapy
Volume 14, 2021 - Issue
Open access
74
Views
4
CrossRef citations to date
0
Altmetric
Review
Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
Nico C Grossmann1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;2 Department of Urology, University Hospital Zurich, Zurich, Switzerland
https://orcid.org/0000-0001-8698-6461View further author information
Victor M Schuettfort1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;3 Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
https://orcid.org/0000-0002-7114-0508View further author information
Benjamin Pradere1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;4 Department of Urology, University Hospital of Tours, Tours, France
https://orcid.org/0000-0002-7768-8558View further author information
Marco Moschini5 Department of Urology, Luzerner Kantonsspital, Luzern, Switzerland
https://orcid.org/0000-0002-3084-2458View further author information
Fahad Quhal1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;6 Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia
https://orcid.org/0000-0002-8163-6953View further author information
Hadi Mostafaei1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;7 Research Center for Evidence Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
https://orcid.org/0000-0001-5596-1771View further author information
Francesco Soria8 Department of Urology, Molinette Hospital, University of Turin, Turin, Italy
https://orcid.org/0000-0001-8443-8453View further author information
Satoshi Katayama1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;9 Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
https://orcid.org/0000-0002-8377-2457View further author information
Ekaterina Laukhtina1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;10 Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
https://orcid.org/0000-0002-8953-0272View further author information
Keiichiro Mori1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;11 Department of Urology, The Jikei University School of Medicine, Tokyo, Japan
https://orcid.org/0000-0002-6147-6569View further author information
Reza Sari Motlagh1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;12 Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
https://orcid.org/0000-0002-3819-9911View further author information
Cédric Poyet2 Department of Urology, University Hospital Zurich, Zurich, Switzerland
https://orcid.org/0000-0002-3648-6941View further author information
Mohammad Abufaraj1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;13 Division of Urology, Department of Special Surgery, Jordan University Hospital, The University of Jordan, Amman, Jordan
https://orcid.org/0000-0002-6603-6319View further author information
Pierre I Karakiewicz14 Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, CanadaView further author information
, Shahrokh F Shariat1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria;10 Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia;15 Department of Urology, Weill Cornell Medical College, New York, NY, USA;16 Department of Urology, University of Texas Southwestern, Dallas, TX, USA;17 Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;18 Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria;19 European Association of Urology Research Foundation, Arnhem, NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0002-6627-6179View further author information
David D’Andrea1 Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Vienna, Austria
https://orcid.org/0000-0003-1625-1077View further author information
Pages 315-324
|
Published online: 13 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.